Abstract
Mucormycosis is an angioinvasive disease caused by saprophytic fungi of the order Mucorales. There are growing reports of rhino-orbital mucormycosis in people with SARS COV-2, especially those from India. Diabetes mellitus (DM) is a very dangerous factor in COVID-19 and mucormycosis. We aim to conduct a retrospective study to determine patient characteristics of mucormycosis and COVID-19 from December 2020 to December 2021 at our tertiary care hospital, North India. During our study time, we have come across 7 such patients. Diabetes mellitus was a major risk factor for all patients with rhino-orbital cerebral mucormycosis. There was a high prevalence among males and the average age of presentation was 51years. All patients received the same treatment with steroids and amphotericin B as well as local anesthetics. Deaths were 42.8%. Our study concludes that patients infected with COVID 19 are easily infected with mucormycetes due to immunosuppression, dysfunction of phagocytes and lymphocytes, and the use of antibodies and steroids.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
